Literature DB >> 9512230

Low pregnancy rate is achieved in patients treated with intracytoplasmic sperm injection due to previous low or failed fertilization in in-vitro fertilization.

C Tomás1, M Orava, L Tuomivaara, H Martikainen.   

Abstract

The main indications for intracytoplasmic sperm injection (ICSI) are severe male factor and fertilization failure or a low fertilization rate in previous in-vitro fertilization (IVF) treatments. The fertilization and pregnancy rates after ICSI, however, are seldom reported separately for these two different indications. The aim of this study was to compare the treatment outcome and pregnancy rate after ICSI between 65 patients with previous failed fertilization or a low fertilization rate without male factor, and 219 patients with a primary male factor. From the 2726 oocytes collected, 2087 (77%) were micro-injected and 1355 (65%) achieved normal fertilization. The oocyte fertilization rate was similar in the group with previous failed fertilization or a low fertilization rate and the group with a male factor (65 and 65% respectively), as was the cleavage rate of normally fertilized oocytes (92 and 94% respectively). Despite the similar fertilization and cleavage rates and the similar number and morphological quality of embryos transferred in both groups, the pregnancy rate was significantly lower (P < 0.05) in the group with previous failed fertilization or a low fertilization rate than in the group with a male factor (19.6 versus 33.5% respectively; 95% confidence intervals for the difference, 2-26%). The implantation rate was also lower (P = 0.01) in patients with previous failed fertilization or a low fertilization rate (9.6%) than in the group with a male factor (19.5%). We conclude that patients with previous failed fertilization or a low fertilization rate in standard IVF without male factor have a significantly smaller chance of becoming pregnant after subsequent ICSI than patients with a primary male factor. This poor outcome probably reflects intrinsic oocyte defects not bypassed by ICSI.

Entities:  

Mesh:

Year:  1998        PMID: 9512230     DOI: 10.1093/humrep/13.1.65

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  7 in total

Review 1.  Complete fertilization failure in ICSI.

Authors:  Kaoru Yanagida
Journal:  Hum Cell       Date:  2004-12       Impact factor: 4.174

2.  Fertilization, embryo quality, and cryosurvival in in vitro fertilization and intracytoplasmic sperm injection cycles.

Authors:  J M Moilanen; M Tulppala; I Reima; O Hovatta
Journal:  J Assist Reprod Genet       Date:  1999-01       Impact factor: 3.412

3.  In vitro fertilization and intracytoplasmic sperm injection for couples with unexplained infertility after failed direct intraperitoneal insemination.

Authors:  S Takeuchi; H Minoura; T Shibahara; X Shen; N Futamura; N Toyoda
Journal:  J Assist Reprod Genet       Date:  2000-10       Impact factor: 3.412

4.  Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection.

Authors:  Wendy S Vitek; Omar Galárraga; Peter C Klatsky; Jared C Robins; Sandra A Carson; Andrew S Blazar
Journal:  Fertil Steril       Date:  2013-07-19       Impact factor: 7.329

5.  In vitro fertilization/intracytoplasmic sperm injection for male infertility.

Authors:  Rubina Merchant; Goral Gandhi; Gautam N Allahbadia
Journal:  Indian J Urol       Date:  2011-01

Review 6.  Opportunities and Limits of Conventional IVF versus ICSI: It Is Time to Come off the Fence.

Authors:  Martina Balli; Anna Cecchele; Valerio Pisaturo; Sofia Makieva; Giorgia Carullo; Edgardo Somigliana; Alessio Paffoni; Paola Vigano'
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

7.  Correlation analysis of human embryo LeY glycan antigen expression and embryo quality.

Authors:  Juan Gu; Linlin Sui; Yanni Ma; Zhenzhen Guo; Man Zhang; Chenyang Zhu; Zhu Cai; Ying Kong
Journal:  Exp Ther Med       Date:  2017-05-22       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.